Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...
A federal judge will soon decide whether to dismiss a lawsuit against UnitedHealth Group alleging that the company and its ...
Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology's ability ...
What are "indirect costs" for universities? Why are some young scientists looking at opportunities abroad? And why are AI ...
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
Cornerstone Research recently issued its 2024 Year in Review report examining recent trends in securities class action filings. For the second year ...
News Medical on MSN3d
Insilico Medicine announces developmental candidate benchmarks and timelines for novel therapeutics discovered using generative AIInsilico Medicine ( “Insilico”) , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today ...
The company is developing generative AI methods to design proteins from scratch, with applications in drug discovery and ...
By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...
Perhaps the most promising AI application is its potential to revolutionize medicine by accelerating the drug discovery process to deliver more effective therapies. Several biotechnology companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback